Clinical Trial Update: Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia [Phase 4]

View source ↗

Summary

Phase 4 trial comparing atorvastatin to simvastatin in type 2 diabetes patients with hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Hypercholesterolemia | Phase 4 | Status: COMPLETED